| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6817 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 |
| filingDate |
2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e6bf37590bfe3fe8ffb34db8ad57c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49dcdfb886b63f290cacaa6142ac620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c349fed2cf55d390ab25cadd77d6d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5b3e8edcae106d693a87c7dcc09b9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9298bc5428b73b1e5d9198259446738c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_870795a44b48d39dad91a77f5d3d9ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfa2f5a84b9e071c312cddd581f3de9 |
| publicationDate |
2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2014364812-A1 |
| titleOfInvention |
Cytotoxic peptides and conjugates thereof |
| abstract |
Disclosed herein are novel cytotoxic peptides of formula (I) as described herein: Formula (I) and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel cytotoxic peptide linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders. |
| priorityDate |
2013-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |